Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-137026
Filing Date
2021-04-28
Accepted
2021-04-28 16:42:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4943
  Complete submission text file 0001193125-21-137026.txt   5848
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations